Published in J Hand Surg Am on May 01, 1983
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (1997) 3.27
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res (1969) 2.60
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet (1974) 2.29
Detailed alignment of saccharum and sorghum chromosomes: comparative organization of closely related diploid and polyploid genomes. Genetics (1998) 2.24
The regional acceleratory phenomenon: a review. Henry Ford Hosp Med J (1983) 2.13
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
The osteoporosis of rheumatoid arthritis. Arthritis Rheum (1965) 2.05
ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost (1989) 1.86
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2001) 1.73
Estrogen and bone-muscle strength and mass relationships. Bone (1998) 1.72
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci U S A (1999) 1.60
Water immersion versus standard colonoscopy insertion technique: randomized trial shows promise for minimal sedation. Endoscopy (2010) 1.56
Post-traumatic anterior ankle instability. Clin Orthop Relat Res (1968) 1.54
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet (1981) 1.49
State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation (2001) 1.47
Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature (1965) 1.46
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun (1994) 1.44
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis (1991) 1.40
The "muscle-bone unit" in children and adolescents. Calcif Tissue Int (2002) 1.35
Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther (1999) 1.31
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res (2001) 1.25
Metastatic tumors of the hand: a report of six cases. J Hand Surg Am (1978) 1.24
Bone resorption rates in rib in physiological, senile, and postmenopausal osteoporoses. J Lab Clin Med (1967) 1.20
Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20
Increased platelet aggregates in patients with transient ischemic attacks. Stroke (1975) 1.20
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care (1999) 1.16
Aspirin and salicylate: An old remedy with a new twist. Circulation (2000) 1.15
Fallibility of the clinical diagnosis of venous thrombosis. JAMA (1975) 1.14
Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem (2001) 1.12
Perspectives: some roles of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research. Calcif Tissue Int (1998) 1.10
Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun (1995) 1.10
A chondral modeling theory. Calcif Tissue Int (1979) 1.10
Recent progress in osteomalacia and rickets. Ann Intern Med (1967) 1.09
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb (1993) 1.08
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb (1993) 1.08
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb Haemost (1976) 1.06
Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J Biol Chem (1994) 1.06
Smoking cessation among Hong Kong Chinese smokers attending hospital as outpatients: impact of doctors' advice, successful quitting and intention to quit. Asia Pac J Public Health (2004) 1.06
Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation (1995) 1.05
New bone formation and osteoid seam thickness. Appositional rate in patients undergoing renal dialysis. Arch Pathol (1969) 1.04
Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop Relat Res (1979) 1.04
Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. J Clin Invest (1988) 1.03
Osteoblastoma of the spine. A review and report of eight new cases. Clin Orthop Relat Res (1973) 1.02
Metastatic tumors of the foot. South Med J (1978) 1.02
Cellular-level bone resorption in chronic renal failure and primary hyperparathyroidism. A tetracycline-based evaluation. Calcif Tissue Res (1970) 1.01
Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem (2000) 1.01
Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med (1978) 1.00
Renal resistance to parathyroid hormone with osteitis fibrosa: "pseudohypohyperparathyroidism". Am J Med (1972) 1.00
Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem (1996) 1.00
Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J Biol Chem (2001) 1.00
Measurement of the bone formation rate in a case of familial hypophosphatemic vitamin D-resistant rickets. J Lab Clin Med (1966) 0.99
Mechanical determinants of bone modeling. Metab Bone Dis Relat Res (1982) 0.99
A determinant of bone architecture. The minimum effective strain. Clin Orthop Relat Res (1983) 0.98
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98
Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem (1995) 0.97
Tetracycline-based study of bone dynamics in pycnodysostosis. Clin Orthop Relat Res (1971) 0.97
Characterization of the roles of the 594-645 region in human endothelial nitric-oxide synthase in regulating calmodulin binding and electron transfer. J Biol Chem (2000) 0.96
Soluble thrombomodulin as predictor of incident coronary heart disease. Lancet (1999) 0.96
Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation (2000) 0.96
Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis (1992) 0.96
Detection of deep vein thrombosis with an automatic electrically calibrated strain gauge plethysmograph. Surgery (1977) 0.95
Characterization of the promoter of human prostaglandin H synthase-1 gene. Biochem Biophys Res Commun (1993) 0.94
Molecular cloning and characterization of bovine prostacyclin synthase. Biochem Biophys Res Commun (1994) 0.94
Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology (1995) 0.94
Relation between bone tissue and cell population dynamics, histology and tetracycline labeling. Clin Orthop Relat Res (1967) 0.93
Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers. J Biol Chem (1997) 0.93
Migratory osteolysis of the lower extremities. Ann Intern Med (1967) 0.93
Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost (1995) 0.93
Periosteal appositional bone growth from age two to age seventy in man. A tetracycline evaluation. Anat Rec (1966) 0.92
Osteoid osteoma--osteoblastoma. Cancer (1974) 0.92
A comparison of methods for the study of platelet hyperfunction in thromboembolic disorders. Br J Haematol (1980) 0.92
Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts. FASEB J (2000) 0.91
Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells. Am J Pathol (1988) 0.91
Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor delta activation: implication in IVF. Hum Reprod (2006) 0.91
The skeletal intermediary organization. Metab Bone Dis Relat Res (1983) 0.91
Albright's hereditary osteodystrophy. Report of a family with studies of bone remodeling. Ann Intern Med (1966) 0.91
Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb (1993) 0.90
Suggested fundamental concepts in skeletal physiology. Calcif Tissue Int (1993) 0.90
Primary structure of human thromboxane synthase determined from the cDNA sequence. J Biol Chem (1992) 0.90
Cerebral palsy. Spastic varus and forefoot adductus, treated by intramuscular posterior tibial tendon lengthening. Clin Orthop Relat Res (1971) 0.90
Prostacyclin stabilising factor deficiency in thrombotic thrombocytopenic purpura. Lancet (1982) 0.90
Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest (1995) 0.89
Extra-osseous chondrosarcoma. Report of five cases and review of the literature. J Bone Joint Surg Am (1980) 0.89
Prostacyclin synthase active sites. Identification by molecular modeling-guided site-directed mutagenesis. J Biol Chem (1997) 0.89
Plasma agouti-related protein level: a possible correlation with fasted and fed states in humans and rats. J Neuroendocrinol (2002) 0.89
Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem (1998) 0.89
Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2000) 0.89
Cyclooxygenase-2 induction in congestive heart failure: friend or foe? Circulation (1998) 0.89
COX-2 expression and cell cycle progression in human fibroblasts. Am J Physiol Cell Physiol (2001) 0.89